<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05618392</url>
  </required_header>
  <id_info>
    <org_study_id>00005</org_study_id>
    <nct_id>NCT05618392</nct_id>
  </id_info>
  <brief_title>Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors</brief_title>
  <acronym>DOULEURGPR</acronym>
  <official_title>Pain Assessment Following Placement of a Percutaneous Radiologic Gastrostomy and Predictive Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier de Valence</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier de Valence</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A 12 months mono-center, descriptive study, to evaluate pain and predictive factors Following&#xD;
      placement of percutaneous Radiologic gastrostomy (PRG).&#xD;
&#xD;
      The primary objective is to evaluate the abdominal pain associated with percutaneous&#xD;
      radiologic gastrostomy (PRG) placement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRG is a pathway first of all enteral nutrition that has several advantages: local&#xD;
      anesthesia, possible in case of esophageal stenosis, Rates of successful tube placement&#xD;
      higher for radiologic gastrostomy than for percutaneous endoscopic Gastrostomy (PEG).&#xD;
&#xD;
      Abdominal pain following percutaneous radiologic gastrostomy (PRG) placement is a recognized&#xD;
      complication. However, the prevalence and degree of severity of pain are poorly&#xD;
      characterized. This pain often requires antalgic treatment.&#xD;
&#xD;
      The primary objective is to evaluate the abdominal pain from Baseline until 7 days after&#xD;
      radiologic gastrostomy (PRG) placement.&#xD;
&#xD;
      The secondary objective is to evaluate predictive factors&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 14, 2022</start_date>
  <completion_date type="Anticipated">March 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>abdominal pain</measure>
    <time_frame>7 days</time_frame>
    <description>numerical scale 0 to 10, with 0 being &quot;no pain&quot; and 10 being &quot;the worst pain imaginable.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>predictive factors</measure>
    <time_frame>DAY 1</time_frame>
    <description>determine predictive factors of pain suspected in advance:&#xD;
Fasting anterior stomach wall depth estimated during the ultrasound survey(mm)&#xD;
Gastric topography determined under X-ray (subcostal / partially retrohepatic)&#xD;
Topography of the anchors: large tuberosity / antrum&#xD;
Distance of anchors from each other (mm)&#xD;
Depth of the anchors (mm)&#xD;
Skin depression of anchors: (with depression, without depression)&#xD;
Intraparietal length of the gastrostomy tube (mm)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Gastrostomy Complications</condition>
  <condition>Gastrostomy</condition>
  <arm_group>
    <arm_group_label>single group assignment</arm_group_label>
    <description>only one arm. Each patient complete numerical scale questionnaire (0-10)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients needing a Percutaneous radiologic Gastrostomy under local anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Needing a radiologic gastrostomy under local anesthesia&#xD;
&#xD;
          -  Age â‰¥ 18 years old&#xD;
&#xD;
          -  Read, write and understand the French language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under guardianship, deprived of liberty, safeguard of justice&#xD;
&#xD;
          -  Patient presenting a serious psychiatric pathology that does not allow compliance with&#xD;
             the completion of the questionnaires (at the discretion of the investigator)&#xD;
&#xD;
          -  Refusal to participate in research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mathilde FINOT, MD</last_name>
    <phone>+33475818870</phone>
    <email>mfinot@ch-valence.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume BUIRET, MD</last_name>
    <phone>+33475818870</phone>
    <email>gbuiret@ch-valence.fr</email>
  </overall_contact_backup>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>June 3, 2022</study_first_submitted>
  <study_first_submitted_qc>November 10, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>November 10, 2022</last_update_submitted>
  <last_update_submitted_qc>November 10, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

